Clinical Trial Update: A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors

View source ↗

Summary

This is a prospective cohort study evaluating immune checkpoint inhibitors in hepatobiliary cancers. The trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Hepatocellular Carcinoma

Snippet

Sponsor: Asan Medical Center | Conditions: Hepatocellular Carcinoma, Biliary Tract Cancer | Status: ACTIVE_NOT_RECRUITING